|
Peptides
UEV1A Peptide
Background
UEV1A Peptide
Location
15 amino acids near the carboxy terminus of human UEV1A.
Application
UEV1A peptide is used for blocking the activity of UEV1A antibody (Cat. No. 3375). It usually blocks the antibody activity completely in immunoblot analysis by incubating the peptide with equal volume of antibody for 30 min at 37˚C.
Tested Application
Bl
Buffer
PBS containing 0.02% sodium azide
Storage
UEV1A peptide is supplied as 200 μg/ml, 50 μg/vial, in PBS pH7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Store at -20˚C, stable for one year.
Species Reactivity
n/a
Species
H
Short Description
UEV1A peptide
This product belongs to the following categories:
Related Products
References- Roy N, Mahadevan MS, McLean M, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995; 80:167-78.
- Liston P, Fong WG, Korneluk RG. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 2003; 22:8568-80.
- Verhagen AM, Coulson EJ, and Vaux DL. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol. 2001; 2:reviews3009.1–reviews3009.10.
- Davoodi J, Lin L, Kelly J, et al. Neuronal apoptosis-inhibitory protein does not interact with Smac and requires ATP to bind caspase-9. J. Biol. Chem. 2004; 279:40622-8.
Datasheet 0801-W
|
|
